ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,811.80
-0.46%
S&P ASX All Technology
3,103.10
0.92%
Brent Oil
80.97
-0.69%
US Dollar vs AUD
1.51151
0.05%
Bitcoin
67,874.93
-1.78%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Correvio Pharma Corporation (CORV)

  7. Correvio Pharma Corporation (CORV) News

CORV

Correvio Pharma (CORV)

Correvio Pharma Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CORV
DateTimeSourceHeadlineSymbolCompany
09/06/202020:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CORVCorrevio Pharma Corporation
28/05/202020:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CORVCorrevio Pharma Corporation
28/05/202020:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CORVCorrevio Pharma Corporation
28/05/202006:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
28/05/202003:01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CORVCorrevio Pharma Corporation
27/05/202020:06Edgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 193...NASDAQ:CORVCorrevio Pharma Corporation
27/05/202020:03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202020:03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202020:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202020:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CORVCorrevio Pharma Corporation
27/05/202007:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CORVCorrevio Pharma Corporation
22/05/202006:50Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
22/05/202006:01PR Newswire (US)Correvio Obtains Final Order for Plan of ArrangementNASDAQ:CORVCorrevio Pharma Corporation
22/05/202006:01PR Newswire (Canada)Correvio Obtains Final Order for Plan of ArrangementNASDAQ:CORVCorrevio Pharma Corporation
18/05/202020:03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
16/05/202007:55PR Newswire (Canada)Correvio Announces Results from Annual General and Special Meeting of SecurityholdersNASDAQ:CORVCorrevio Pharma Corporation
16/05/202007:55PR Newswire (US)Correvio Announces Results from Annual General and Special Meeting of SecurityholdersNASDAQ:CORVCorrevio Pharma Corporation
07/05/202003:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
06/05/202022:00PR Newswire (US)Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVAN...NASDAQ:CORVCorrevio Pharma Corporation
06/05/202022:00PR Newswire (Canada)Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVAN...NASDAQ:CORVCorrevio Pharma Corporation
05/05/202002:46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
04/05/202022:00PR Newswire (US)Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19NASDAQ:CORVCorrevio Pharma Corporation
04/05/202022:00PR Newswire (Canada)Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19NASDAQ:CORVCorrevio Pharma Corporation
02/05/202003:32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
01/05/202022:00PR Newswire (US)Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMANASDAQ:CORVCorrevio Pharma Corporation
01/05/202022:00PR Newswire (Canada)Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMANASDAQ:CORVCorrevio Pharma Corporation
30/04/202020:23Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CORVCorrevio Pharma Corporation
21/04/202011:56PR Newswire (US)SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?NASDAQ:CORVCorrevio Pharma Corporation
18/04/202007:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:CORVCorrevio Pharma Corporation
17/04/202007:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CORVCorrevio Pharma Corporation
 Showing the most relevant articles for your search:NASDAQ:CORV

Your Recent History

TSXV
DGTL
DGTL
BIT
P1YCV3
NLBNPIT1YCV3 20351221 8....
NASDAQ
IBCP
Independent Bank
LSE
QL76
Morg.st.b.v 26
COIN
DAPPTEUR
Dapp Token
NASDAQ
OLED
Universal Display
GATE
PERLUSDT
Perlin
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved